NasdaqGS - Nasdaq Real Time Price USD

Bruker Corporation (BRKR)

80.97

+0.38

(+0.47%)

At close: 4:00 PM EDT

80.97

0.00

(0.00%)

After hours: 4:01 PM EDT

Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference

BARCELONA, Spain, April 26, 2024--At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying microbiology and infectious disease diagnostics and workflows in the clinical laboratory is a key goal for Bruker in support of earlier and improved patient treatment decisions.

Business Wire 10 hours ago

BRKR
+0.47%
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast

BILLERICA, Mass., April 25, 2024--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.

Business Wire yesterday

BRKR
+0.47%
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks yesterday

BRKR
+0.47%
Bruker to Acquire the NanoString Business in an Asset Deal

BILLERICA, Mass., April 22, 2024--Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of solutions for spatial transcriptomics and gene expression analysis.

Business Wire 4 days ago

BRKR
+0.47%
Bruker to acquire Nanostring for $393M

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

MedTech Dive 8 days ago

BRKR
+0.47%
TXG
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.

Zacks 17 days ago

BRKR
+0.47%
SYK

CAH
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates

ASILOMAR, Calif., April 08, 2024--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.

Business Wire 18 days ago

BRKR
+0.47%
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies

ASILOMAR, Calif., April 08, 2024--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).

Business Wire 18 days ago

BRKR
+0.47%
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing immunoassay platforms to be presented at the AACR 2024 Annual Meeting ZURICH, Switzerland and FREMONT, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company po

GlobeNewswire 22 days ago

BRKR
+0.47%
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook

BILLERICA, Mass., April 01, 2024--Bruker Corporation (NASDAQ: BRKR) has been selected as the Instrument Business Outlook (IBO) ‘Company of the Year’ for 2023. IBO cited Bruker’s double-digit organic revenue growth in 2023 in all major regions, and in all business groups, demonstrating a transformed portfolio and operational strength.

Business Wire 25 days ago

BRKR
+0.47%
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.

Zacks last month

BRKR
+0.47%
CAH
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

BRKR
+0.47%
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?

Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.

Zacks last month

BRKR
+0.47%
SYK

CAH
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO

Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.

Zacks last month

BRKR
+0.47%
CAH

DVA
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

PORTLAND, Ore., March 11, 2024--At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The rapid advances in deep, at-scale proteomics, glycomics and peptidomics research solutions complement other performance-leading life-science tools for the post-genomic era by Bruker. Together they enable post-genomic molecular and cell biology research, with key insigh

Business Wire last month

BRKR
+0.47%
Bruker Announces Closing of Chemspeed Technologies AG Acquisition

BASEL, Switzerland, March 07, 2024--Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization, and laboratory automation – altogether an important initiative within Bruker’s

Business Wire last month

BRKR
+0.47%
Director Hermann Requardt Sells 15,000 Shares of Bruker Corp (BRKR)

Director Hermann Requardt has sold 15,000 shares of Bruker Corp (NASDAQ:BRKR) on March 4, 2024, according to a recent SEC Filing.

GuruFocus.com last month

BRKR
+0.47%
Here's Why Investors Should Retain Bruker (BRKR) Stock Now

The strength of the BSI BioSpin and CALID groups bodes well for Bruker (BRKR).

Zacks last month

BRKR
+0.47%
Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup

Bruker (BRKR) announces a share purchase agreement to acquire the molecular diagnostics innovator ELITechGroup.

Zacks last month

BRKR
+0.47%
CAH

DVA
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup

TORINO, Italy, February 28, 2024--Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, to acquire ELITechGroup, for €870 million in cash, excluding the carved out ELITech clinical chemistry business. As reported in an 8-K SEC filing on December 26, 2023, Bruker had previously entered into a put option agreement with the sellers, pending work

Business Wire last month

BRKR
+0.47%

Performance Overview

Return	BRKR	S&P 500
YTD	+10.26%	+6.92%
1-Year	+5.53%	+25.26%
3-Year	+17.44%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bruker Corporation (BRKR)

Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference

Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast

Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

Bruker to Acquire the NanoString Business in an Asset Deal

Bruker to acquire Nanostring for $393M

Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates

Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?

Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?

Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

Bruker Announces Closing of Chemspeed Technologies AG Acquisition

Director Hermann Requardt Sells 15,000 Shares of Bruker Corp (BRKR)

Here's Why Investors Should Retain Bruker (BRKR) Stock Now

Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup

Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup

Performance Overview